LONDON, Nov. 1, 2017 /PRNewswire/ -- Separation Systems for Commercial Biotechnology Market Analysis By Methods (Microarray,
Lab-on-a-chip, Chromatography, Flow Cytometry, Biochip), By Application, And Segment Forecasts, 2014 - 2025Download the full report: https://www.reportbuyer.com/product/5171144The global separation system for commercial biotechnology market is expected to reach USD 39.47 billion by 2025, according to a new report by Grand View Research, Inc.
Intensive research in the field of biotechnology to develop advanced products is expected to boost growth in the coming years. Moreover, contributions of leading industrial entities in this sector for accelerating commercial production is anticipated to drive the market.Government bodies are providing funds to small & medium enterprises for the development of novel technologies. This is expected to enhance the efficiency of large-scale upstream bioprocessing systems used for separation & purification of biomolecules. Such instruments are extensively used for production of food & cosmetics, agriculture, plastics, and chemicals.Moreover, the popularity of technologically advanced single-use bioprocessing systems in various industries, such as agro-processing, chemical & plastics is contributing toward the growth of the upstream processing sector. Rising cases of chronic & severe metabolic & genetic disorders are ultimately increasing the demand of potential therapeutics. Rising demand for biopharmaceuticals is likely to result in lucrative growth.Furthermore, changing healthcare reforms and public -private collaborations among industrial players, government, and research institutions are expected to improve the technological aspects of separation methods. Thus, in turn, is anticipated to significantly render the growth of commercial separation market over the forecast period.Further Key Findings from the Report Suggest:• Conventional separation techniques are estimated to account for the largest revenue share owing to technological advancements in the segment• However, modern methods are anticipated to grow at the fastest pace in the coming years due to rise in adoption of these technologies• Technological advancements in product capabilities are anticipated to boost the market• Pharmaceutical industry accounted for the largest revenue share owing to higher usage of systems for commercialization of therapeutics• Rising prevalence of various chronic disorders is indirectly boosting growth• North America dominated the market with adequate administration support, extensive research, and well-established industrial framework• Asia Pacific region is expected to exhibit fastest growth over the forecast period owing to progressive industrialization and favorable government support• Major players include Shimadzu Corporation; PerkinElmer, Inc.; Agilent Technologies; GE Healthcare; Thermo Fisher Scientific; Bio-Rad Laboratories, Inc.; bioMérieux SA; Merck & Co., Inc.; WATERS; Hitachi Koki Co., Ltd.; QIAGEN; Sartorius;BD; Danaher; and Miltenyi Biotec• Companies are entering into collaborations with academic institutions, private, and public entities to accelerate product development and launch novel systemsDownload the full report: https://www.reportbuyer.com/product/5171144 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers https://www.reportbuyer.com For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected] Tel: +44 208 816 85 48 Website: www.reportbuyer.com
View original content:http://www.prnewswire.com/news-releases/the-global-separation-system-for-commercial-biotechnology-market-is-expected-to-reach-usd-3947-billion-by-2025-300548172.html